Skip to content

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Community Preparedness for Outbreak Response and Readiness for ZEBOV Vaccination in Liberia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05888649
Enrollment
1500
Registered
2023-06-05
Start date
2023-06-30
Completion date
2025-04-30
Last updated
2023-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ebola Virus Disease

Keywords

Community Preparedness, Outbreak Response, Ebola Virus Disease (EVD), Ebola Vaccine, Ebola Vaccine Acceptance, Community Leaders, Liberia

Brief summary

This community-based mixed methods study intends to identify, explore, and assess the determinants of community preparedness for outbreak situations, including acceptance for Ebola vaccines.

Detailed description

This community-based study intends to identify, explore, and assess the determinants of community preparedness for outbreak situations and acceptance for the administration of Ebola vaccination. The investigators will conduct an anthropologically driven mixed methods study design that comprises both qualitative and quantitative research methods for the successful implementation of this community-based study. The investigators will conduct structured interviews with community members and local responders to broadly assess and understand the perspectives regarding appropriate strategies previously employed to effectively support community preparedness during outbreak response and also to broadly access and understand appropriate strategies previously employed to effectively support community acceptance for Ebola vaccines, respectively. Learning from the experiences of local voices produces globally emergent systems that are trusted, reliable and sustainable.

Interventions

BEHAVIORALCommunity Clusters

Assessment of the determinants for community preparedness to EVD outbreaks and acceptance of EVD vaccines.

Sponsors

West African Consortium for Clinical Research on Epidemic Pathogens (WAC-CREP)
CollaboratorUNKNOWN
UL-PIRE Africa Center
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults * Community Leaders * Community Members * Reside in 1 of 3 highly prevalent counties * Participated actively in EVD outbreaks related activities * Documented roles recognized by the Incident Management System

Exclusion criteria

* Not Adults * Does not reside in any of the 3 highly prevalent counties * Did not actively participate in the EVD outbreak response related activities * Roles not documented by the Incident Management System

Design outcomes

Primary

MeasureTime frameDescription
Measure #12 YearsAssess Community Preparedness with the Resiliency Scale
Measure #22 YearsAssess Community Acceptance of EVD Vaccine with the Resiliency Scale

Secondary

MeasureTime frameDescription
Measure #32 YearsAssess Roles of Community Leaders with the Resiliency Scale
Measure #42 YearsAssess Roles of Formal and Informal Community Structures with the Resiliency Scale

Countries

Liberia

Contacts

Primary ContactStephen B Kennedy, MD, MPH
sbkennedy4@gmail.com+231770645830
Backup ContactHannah Berrian, MPH
hannahberrian@gmail.com+231777938203

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026